gimli
ERIS stock AI analysis

ERIS Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers

ERIS LIFESCIENCES LIMITED is a small-cap stock in Healthcare. This Gimli page shows the latest available ERIS price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.

Price
₹1,329.70
1W return
+7.75%
1M return
+16.19%
3M return
-2.12%
6M return
-3.01%
1Y return
-14.24%
Market cap
₹18,425.29 cr
PE
25.65
PB
4.45
ROE
+20.00%
ROCE
+13.79%
RSI
73.31
Turnover
₹23.93 cr

Why it can matter in screens

Quick Answers

What is the latest ERIS stock price?

The latest stored price for ERIS is Rs 1,329.70 as of 2026-11-16.

Is ERIS above its 50DMA and 200DMA?

ERIS is above 50DMA, below 200DMA. The latest 50DMA is 1,227.96 and the latest 200DMA is 1,340.65.

What are ERIS PE, ROE and ROCE?

ERIS has PE 25.65, ROE +20.00%, and ROCE +13.79% in Gimli's latest available snapshot.

How has ERIS performed recently?

ERIS has returned +16.19% over 1 month, -2.12% over 3 months, and -14.24% over 12 months in the latest stored data.

Is this stock page investment advice?

No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.

Financials and Ownership

Quarterly income statement

PeriodRevenueEBITDAPATEPS
2026-09-30889.50 cr275.75 cr183.82 cr13.26
2026-06-30869.03 cr298.21 cr142.39 cr10.28
2026-03-31752.29 cr274.60 cr281.61 cr20.60
2025-12-31800.89 cr264.51 cr108.80 cr7.32
2025-09-30790.15 cr291.30 cr134.50 cr8.82
2025-06-30771.56 cr280.29 cr117.99 cr8.66
2025-03-31702.60 cr260.35 cr93.84 cr6.90
2024-12-31722.12 cr254.33 crn/anan

Annual income statement

YearRevenueEBITDAPATEPS
2026-03-313,114.89 cr1,110.71 cr619.50 cr45.33
2025-03-312,879.26 cr1,035.62 cr351.84 cr25.85
2024-03-311,991.30 cr698.65 cr392.05 cr28.82
2023-03-311,661.82 cr547.90 cr382.16 cr28.10
2022-03-311,244.72 cr511.05 cr417.19 crnan

Balance sheet

PeriodAssetsCashDebtEquity
2026-03-317,365.51 cr54.74 cr2,358.62 cr3,895.66 cr
2025-03-317,033.17 cr199.64 cr2,477.92 cr3,271.76 cr
2024-03-317,040.46 cr94.14 cr2,781.28 cr3,222.09 cr
2023-03-313,667.33 cr55.95 cr876.71 cr2,220.68 cr
2022-03-312,272.14 cr50.87 cr84.40 cr1,908.20 cr

Cash flow

PeriodOCFFCFCash change
2026-03-31537.99 cr241.13 crn/a
2025-03-311,065.01 cr910.01 crn/a
2024-03-31486.01 cr356.85 crn/a
2023-03-31291.74 cr-549.68 crn/a
2022-03-31378.26 cr257.23 crn/a

Shareholding Trend

PeriodPromoterFII/FPIDIIMFRetailPledge
2026-09-30+54.74%+5.74%+20.20%+17.98%+19.32%+21.25%
2026-06-30+54.14%+5.75%+20.72%+18.88%+19.40%+16.85%
2026-03-31+53.92%+6.39%+20.35%+18.22%+19.33%+16.92%
2025-12-31+54.85%+6.85%+20.32%+18.26%+17.99%+16.92%
2025-09-30+54.85%+7.21%+19.36%+17.33%+18.57%+16.92%
2025-06-30+54.83%+8.40%+18.17%+16.78%+18.59%+16.93%
2025-03-31+54.85%+8.43%+18.07%+16.59%+18.66%+18.51%
2024-12-31+54.86%+8.35%+18.06%+16.52%+18.72%+18.51%
2024-09-30+54.87%+8.01%+18.64%+17.03%+18.47%+18.51%
2024-06-30+54.88%+14.59%+16.23%+14.52%+14.30%+18.51%
2024-03-31+54.90%+14.27%+15.63%+14.92%+15.19%+18.51%
2023-12-31+54.90%+13.14%+14.56%+13.85%+17.41%+10.95%
2023-09-30+54.91%+13.20%+14.53%+13.86%+17.37%+10.95%
2023-06-30+52.86%+13.78%+10.74%+10.27%+22.63%+11.37%
2023-03-31+52.86%+14.86%+10.02%+9.64%+22.26%+0.00%
2022-12-31+52.70%+15.50%+9.94%+9.64%+21.85%+0.00%
2022-09-30+52.29%+15.39%+10.68%+10.38%+21.64%+0.00%
2022-06-30+52.30%+0.00%+26.01%n/an/a+0.00%
2022-03-31+52.66%+0.00%+23.81%n/an/a+0.00%
2021-12-31+52.66%+0.00%+23.71%n/an/an/a

Industry Peers

SymbolNameMcapPEROE1Y
SUNPHARMASUN PHARMACEUTICAL IND L448,075.81 cr40.781879+14.03%+6.28%
DIVISLABDIVI S LABORATORIES LTD294,139.21 cr87.463339+21.13%+70.16%
TORNTPHARMTORRENT PHARMACEUTICALS L178,438.17 cr85.011038+16.67%+22.43%
APOLLOHOSPAPOLLO HOSPITALS ENTER. L126,113.56 cr53.952325+24.95%+18.20%
LAURUSLABSLAURUS LABS LIMITED119,848.17 cr89.960566+26.71%+122.22%
ZYDUSLIFEZYDUS LIFESCIENCES LTD118,902.46 cr27.636309+15.44%+26.21%
DRREDDYDR. REDDY S LABORATORIES114,723.24 cr41.579949+7.80%+10.59%
CIPLACIPLA LTD112,647.78 cr39.472630+8.80%-8.98%

Try these prompts

Related screen ideas

Data snapshot: 2026-11-16. Not investment advice.